Safety of long-acting beta agonists and inhaled corticosteroids in children and adolescents with asthma

Схожие документы

• Utilization, Spending, and Price Trends for Short- and Long-Acting Beta-Agonists and Inhaled Corticosteroids in the Medicaid Program, 1991–2010
  по: Chiu, Shih-Feng, et al.
  Опубликовано: (2011)
• Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children
  по: Ni Chroinin, Muireann, et al.
  Опубликовано: (2009)
• Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
  по: Dreher, Michael, et al.
  Опубликовано: (2018)
• Asthma Guidelines Priority Topics: Intermittent Inhaled Corticosteroid Therapy and Inhaled Corticosteroids with Long Acting Beta-Agonists as Reliever Therapy
  по: Blake, Kathryn V., et al.
  Опубликовано: (2019)
• Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children
  по: Ducharme, Francine M, et al.
  Опубликовано: (2010)